Keyword

Xeomin

Description: Xeomin is a brand of incobotulinumtoxinA, a botulinum toxin type A medicine used to treat neurological disorders and for cosmetic procedures.
OpenAlex ID: keywords/xeomin
2018 · Mukta Agrawal, Swarnlata Saraf, et al. · Journal of Controlled Release · 709
2010 · Karl-Heinz Eisele, Klaus Fink, et al. · Toxicon · 178
2009 · Joseph Jankovic, Christopher Kenney, et al. · Movement Disorders · 178
2007 · Dirk Dressler, Reiner Benecke · Disability and Rehabilitation · 173
2007 · Wolfgang H Jost, J??rg Bl??mel, et al. · Drugs · 144
2009 · Petr Kaňovský, Jaroslaw Slawek, et al. · Clinical Neuropharmacology · 127
2009 · Luca Carli, Cesare Montecucco, et al. · Muscle & Nerve · 114
2011 · Joseph Jankovic, Cynthia Comella, et al. · Movement Disorders · 111
2006 · R. Bhidayasiri, F. Cardoso, et al. · European Journal of Neurology · 102
2009 · D. Dressler · European Journal of Neurology · 89
2011 · Dirk Dressler, Gerd Mander, et al. · Journal of Neural Transmission · 86
2013 · Virgilio Gerald H. Evidente, Hubert H. Fernandez, et al. · Journal of Neural Transmission · 81
2007 · Kai Wohlfarth, Christian Müller, et al. · Clinical Neuropharmacology · 74
2019 · Francesca Morgante, Ganesh Bavikatte, et al. · Therapeutic Advances in Neurological Disorders · 73
2013 · Xeomin US Blepharospasm Study Group, Daniel D. Truong, et al. · Journal of Neural Transmission · 73
2017 · Amit A. Patel, Michael Z. Lerner, et al. · Annals of Otology Rhinology & Laryngology · 72
2014 · Katja Kollewe, Bahram Mohammadi, et al. · Journal of Neural Transmission · 69
2014 · Dirk Dressler, Fereshte Adib Saberi, et al. · Journal of Neural Transmission · 69
Works count: 423
Citation count: 5,854
Year
Topic
Type